Improving Outcomes of Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma: New Data and Ongoing Trials

Lisha Mou(Shenzhen Metro (China)), Zuhui Pu(Shenzhen Metro (China)), Ying Deng(Nanjing University), Ying Lu(Shanxi Academy of Medical Sciences), Jing Deng(Hangzhou Center for Disease Control and Prevention), Yi’an Song(Shenzhen Second People's Hospital), Xiaohe Tian(Hunan University), Qi Li(China National Center for Food Safety Risk Assessment), Jiao Chen(Shanghai University), Yongqiang Zhan(Shenzhen Second People's Hospital), Yong Ni(Shenzhen Second People's Hospital), Hongyuan Zhang(University of British Columbia), Jinjun Chen(Southern Medical University), Kuifeng Tian(Shenzhen Second People's Hospital), Bo Zhou(Ningxia Medical University), Zijing Wu(Shenzhen Second People's Hospital)
Frontiers in Oncology
October 11, 2021
Cited by 74


Related Papers